Interventional market estimated at $22B by ‘16

The global market for devices and technologies for the interventional cardiology community will top $22 billion by 2016, according to one industry analysis.

Research and Markets reviewed companies that make stents, balloons, catheters, guidewires and accessories as well as intravascular ultrasound, fractional flow reserve and optical coherence tomography (OCT) technologies to project market trends to 2018. The company estimated that the compound annual growth rate for the global interventional cardiology market will increase 9.2 percent through 2018.

The market for devices alone is expected to account for $20 billion of the global market by 2016. North America will capture the largest market share and the Asia-Pacific region will see the greatest growth. 

The analysts pegged the global PCI market to bring in $4.8 billion by 2016, with coronary stents making up the largest portion of devices. They predicted that OCT would be the fastest growing market.

Researchers looked at responses to online surveys, government databases, company websites, reports and press releases. Research and Markets reported that it identified 727 “market players,” of which 122 were profiled in the report.

Candace Stuart, Contributor

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.